Terumo Cardiovascular’s Post

Early investigators of antisense oligos will remember this seminal paper by the Walders and appreciate its impact: Role of RNase H in hybrid-arrested translation by antisense oligonucleotides ROXANNE Y. WALDER and JOSEPH A. WALDER* Department of Biochemistry, University of Iowa Proc. Nati. Acad. Sci. USA Vol. 85, pp. 5011-5015, July 1988 https://lnkd.in/e4Tnz2PB Last paragraph: “For antisense oligodeoxynucleotides to be used to block the expression of selected genes within intact cells, it may be necessary to modify the oligonucleotide to decrease its rate of degradation and improve intracellular transport. An important corollary of our results is that such modified analogs must not only retain normal hybridization properties but should also form substrates that are recognized and cleaved by RNase H.”

🚨The eagerly awaited moment has arrived: the complete agenda for the 9th CAR-TCR Meeting is now available.🚨 Returning as the industry's foremost event of the year, the 9th CAR-TCR Summit serves as your team's ultimate resource for advancing clinical and commercial development. Dive into cutting-edge scientific data, participate in solution-driven discussions to overcome development challenges, and forge new collaborations to propel clinical and commercial progress. This program showcases experts from innovation, clinical, and commercial sectors, providing insights to improve durability, cost-efficiency, and clinical outcomes alongside companies such as Arsenal Bio, BMS, Cartesian Therapeutics, Cellectis, Legend Biotech, Novartis, and UPenn. Whether you're a C-level decision-maker or a frontline scientist, this meeting suits your needs. There's something for everyone at CAR-TCR - view the full event guide to see what all the excitement is about: https://ter.li/q62olq

We are excited to introduce our new executive board members who assumed their roles on July 1st! Discover more about them and our organizational structure at the following link—

LATAM DHR ONE SITE - Brand new show room Yesterday I had the privilege to see the brand new show room at LATAM DHR ONE SITE, in São Paulo. Scale models are a great alternative due to their cost-effectiveness and flexibility; you can easily transport them to trade shows and adapt them to align with current strategies. At Beckman Coulter Life Sciences, we chose to showcase the Pharma workflow, and this is the impressive result. T his project was a significant challenge due to time and budget constraints but through teamwork, we successfully brought it to fruition. THE BEST TEAM WINS! Danaher Corporation Beckman Coulter Life Sciences #LSIG #LifeSciences #PharmaInnovation #Teamwork #ProjectManagement #TradeShowExcellence #CostEffectiveSolutions #ModelShowcase #Collaboration #SuccessStories #SãoPauloEvents #InnovationInPharma #FlexibleDesign Keila Cristina Junqueira dos Santos Maria Carla Abdo Daniela Souza Turato Vitor Teixeira João Vanessa Lobo

Health-tech from Slovakia 🧑⚕️🇸🇰 Together with Pavol Cekan's MultiplexDX, Michaela Šišková's DNA ERA and others, Forbes Slovensko selected Powerful Medical as one of the most perspective health-tech companies from Slovakia 🙌

With J&Js recent acquisition of Shockwave Medical, I think it's fair to say M&A is front of mind for everyone in the industry. Definitely one to block out in your calendar!

Sujith Shetty Mark McIlduff and I are eager to connect with innovators and industry leaders next week to explore the latest trends and uncover new opportunities to advance cardiovascular technology. Message me if you are interested in catching up live. #CardiovascularTech #CardiovascularInnovation #CRO #ProductDevelopment

Where Innovation is

Almac is a truly unique company! The McClay Foundation, which wholly owns The Almac Group, was founded by Sir Allen McClay and exists to make meaningful improvement and advancement in human health. The McClay Foundation’s objectives are: 1. To support and encourage research and innovation. 2. To advance the use of diagnostic tools and drugs in the prevention, control and cure of diseases. 3. To ensure latest advances in healthcare are available to all, including developing countries. 4. To generate and promote employment opportunities. 5. To support and promote such educational purposes as the trustees shall select The McClay Foundation’s four strategic focus areas are: • Research and Development of New Medicines • Oncology Research - Targets and Biomarkers • Research led care for those in end of life or life limited circumstances • Promoting health and wellbeing in disenfranchised communities and geographical locations With 18 locations and a further 60 depots around the world, we are where our clients and patients need us to be. Sir Allen McClay’s vision for Almac continues to drive our daily focus on partnering to advance human health. 🌟 Discover Almac: A Pioneer in Advancing Human Health! 🌟 Find out more: https://lnkd.in/eufZkaXe #biotech #clinicalresearch #clinicaltrials #drugdevelopment #healthcare

I am excited for the discussion! Join us as we share more on how community pharmacies can provide hands on specialty clinical care and services! #communitypharmacy #specialtypharmacy #walmartpharmacy